Macromolécules et microsystèmes en Biologie et en Médecine (MMBM)

The team develops activities at the interface between physics, biology and medicine. Its main specificity is to focus on technological innovations, biophysical and bioanalytical approaches. The team expertise is dedicated to microfluidics, more recently to organ on chip, with the integration of a new nanomedicine therapeutic axis.

The MMBM team is member of UMR 168, Curie Institute, which goal is to uncover the role of physical laws in the architecture and functions of cellular systems as well as a resident team of Institut Pierre Gilles de Gennes for microfluidics (IPGG) which gathers research laboratories from different disciplines and a technological platform dedicated to microfabrication tools and technologies for microfluidics.

Taking benefit of this dual positioning, the current team research relies on the strong interplay between, on one hand, cutting-edges technological developments in microfluidics and nanomedicine and biophysical and clinical challenges, on the other hand. The recent addition to the team of the two permanent researchers C. Wilhelm and A. Van de Walle brings a complementary expertise in bioengineering and nanomedicine. Thanks to Institut Curie scientific and clinical environment combined with a unique set of expertise and skills, we now have the ambition to develop a new generation of bioengineered models that faithfully reproduce in vivo complexity. Such approaches which will be essential for developing and evaluating cutting-edges therapies.